SCHEMBL19080431

SCHEMBL19080431

Cc1ccc2ccccc2c1-c1c(F)cc(Br)c2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 5/20 0.42
▸ CYP2A6 P11509 4/20 0.42
▸ TSHR P16473 3/20 0.42
▸ HPRT1 P00492 1/20 0.39
▸ ALDH1A1 P00352 7/20 0.37
▸ HSD17B10 Q99714 3/20 0.37
▸ HPGD P15428 1/20 0.37
▸ MAPT P10636 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ HSD11B1 P28845 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ LCK P06239 1/20 0.34
▸ FYN P06241 1/20 0.34
▸ ADORA3 P0DMS8 1/20 0.34
▸ ACHE P22303 1/20 0.34
▸ SLC6A2 P23975 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19064465 0.83 HPRT1 (0.38) CYP1A2CYP2A6TSHRHPRT1ALDH1A1
SCHEMBL19064466 0.81 HPRT1 (0.39) CYP1A2CYP2A6TSHRHPRT1ALDH1A1
SCHEMBL19080430 0.81 POLB (0.47) CYP1A2HPRT1ALDH1A1HSD17B10MAPT
SCHEMBL19063384 0.81 MAPT (0.63) HPRT1ALDH1A1HPGDMAPTMEN1
SCHEMBL19080434 0.80 CYP1A2 (0.41) CYP1A2CYP2A6TSHRHPRT1ALDH1A1
SCHEMBL13839779 0.78 TSHR (0.52) CYP1A2CYP2A6TSHRHPRT1ALDH1A1
SCHEMBL2951616 0.77 TSHR (0.65) CYP1A2CYP2A6TSHRHPRT1ALDH1A1
SCHEMBL29352216 0.77 TSHR (0.65) CYP1A2CYP2A6TSHRHPRT1ALDH1A1
SCHEMBL19080441 0.77 CYP2D6 (0.34) CYP1A2HPRT1ALDH1A1HPGDMAPT
SCHEMBL27904278 0.76 CYP1A2 (0.50) CYP1A2CYP2A6TSHRALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 CYP1A2 621/4885CYP2A6 1716/4885TSHR 4409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback